Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Non Operating Income (2022 - 2025)

Historic Non Operating Income for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $3.2 million.

  • InflaRx's Non Operating Income rose 4155.57% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 149809.12%. This contributed to the annual value of $3.4 million for FY2024, which is 24260.0% up from last year.
  • According to the latest figures from Q3 2025, InflaRx's Non Operating Income is $3.2 million, which was up 4155.57% from $1.7 million recorded in Q2 2025.
  • InflaRx's Non Operating Income's 5-year high stood at $5.8 million during Q4 2024, with a 5-year trough of -$4.9 million in Q1 2025.
  • Moreover, its 4-year median value for Non Operating Income was -$678124.0 (2022), whereas its average is $89136.5.
  • In the last 5 years, InflaRx's Non Operating Income plummeted by 68606.05% in 2024 and then surged by 20154.64% in 2025.
  • InflaRx's Non Operating Income (Quarter) stood at $3.7 million in 2022, then fell by 24.07% to $2.8 million in 2023, then surged by 107.2% to $5.8 million in 2024, then crashed by 44.61% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $1.7 million for Q2 2025, and -$4.9 million during Q1 2025.